BPC-157 vs LL-37.
Quick Verdict
BPC-157 is a body protective compound primarily researched for injury recovery, gut healing, tissue repair, reduced inflammation, while LL-37 is a antimicrobial peptide studied for broad-spectrum antimicrobial, anti-biofilm, wound healing, immune modulation, anti-inflammatory.
Side-by-Side Analysis
| Dimension | BPC-157 | LL-37 |
|---|---|---|
| Category | Body Protective Compound | Antimicrobial Peptide |
| Mechanism | Promotes angiogenesis, collagen deposition, and modulates growth factors for accelerated healing. | The only human cathelicidin antimicrobial peptide. |
| Half-Life | ~4 hours | ~4 hours |
| Route | SubQ | SubQ |
| Typical Dose | 250–500 mcg | 100–100 mcg |
| Frequency | 7x/wk | 7x/wk |
| Evidence Level | Preclinical | Moderate |
| Indexed Studies | 20+ indexed | 20+ indexed |
| FDA Status | Approved | Approved |
| Lowest Price | $39.99 / 10mg via Amino Club | $94.97 / 5mg via Bio Longevity Labs |
| Per-mg Cost | $4.00/mg | $18.99/mg |
Mechanism of Action Comparison
How BPC-157 Works
BPC-157 BPC-157 is a synthetic peptide derived from a protein found in gastric juice, studied in animal research for accelerating injury recovery and gut tissue repair.
Promotes angiogenesis, collagen deposition, and modulates growth factors for accelerated healing. Acts on multiple repair pathways simultaneously including tendon, ligament, muscle, gut lining, and nerve tissue.
How LL-37 Works
LL-37 LL-37 is the only human antimicrobial cathelicidin peptide studied for directly killing bacteria, viruses, and fungi while also promoting wound healing and immune system activation.
The only human cathelicidin antimicrobial peptide. LL-37 is a 37-amino acid cationic peptide that directly disrupts microbial membranes (bacteria, viruses, fungi) and neutralizes bacterial endotoxins (LPS). Beyond direct antimicrobial action, LL-37 modulates innate immunity by chemoattracting neutrophils, monocytes, and T-cells to infection sites. Promotes wound healing via EGFR-mediated keratinocyte migration and angiogenesis. Demonstrates potent anti-biofilm properties against resistant organisms.
Key Mechanistic Difference
BPC-157 operates as a body protective compound, while LL-37 functions as a antimicrobial peptide — these are fundamentally different pharmacological approaches.
Research Evidence
BPC-157
20 studies- BPC-157 tendon, ligament, and gut healing effectsComprehensive review demonstrating potent tendon, ligament, and gut healing effects across multiple preclinical models.…Preclinical
- Stable gastric pentadecapeptide BPC 157 gastrointestinal tract healingRobert et al. demonstrate BPC-157 heals GI ulcers, fistulas, and inflammatory bowel lesions in rats via cytoprotective p…Preclinical
- BPC-157 accelerates Achilles tendon healing in ratsStaresinic et al. show BPC-157 accelerates healing of transected Achilles tendons, enhancing tendon fibroblast outgrowth…Preclinical
LL-37
20 studies- LL-37 broad-spectrum antimicrobial and immunomodulatory effectsComprehensive review of LL-37's dual antimicrobial and immunomodulatory functions, including membrane disruption, chemot…Moderate
- LL-37 anti-biofilm activity against resistant pathogensOverhage et al.: LL-37 inhibits biofilm formation by Pseudomonas aeruginosa at sub-MIC concentrations, affecting bacteri…Preclinical
- LL-37 promotes wound healing via EGFR transactivationTokumaru et al.: LL-37 promotes wound re-epithelialization by stimulating keratinocyte migration through EGFR transactiv…Preclinical
Vendor Pricing
· Affiliate links · Prices verified 2026BPC-157
4 vendorsLL-37
1 vendorAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
Can I take BPC-157 and LL-37 together?▼
Yes — BPC-157 and LL-37 are identified as synergistic in interaction databases. They operate through complementary mechanisms and are commonly combined in research protocols.
Which has more research evidence — BPC-157 or LL-37?▼
BPC-157 has 20 indexed studies (highest evidence: Preclinical). LL-37 has 20 indexed studies (highest evidence: Moderate). Both have comparable research coverage.
What is the price difference between BPC-157 and LL-37?▼
At current verified vendor prices, BPC-157 starts at $4.00/mg while LL-37 starts at $18.99/mg. Prices vary by vendor and vial size — see the full vendor comparison below.
Which is better for injury recovery — BPC-157 or LL-37?▼
Both are researched for injury recovery. BPC-157 addresses this via injury recovery, gut healing, tissue repair, reduced inflammation. LL-37 approaches it through broad-spectrum antimicrobial, anti-biofilm, wound healing, immune modulation, anti-inflammatory. The optimal choice depends on your specific research protocol and which mechanism aligns with your objectives.
Related Comparisons
Deep Dive Profiles
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.